Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Inform Genomics Inc.
Inform Genomics Inc.
While other personalized medicine companies tend to focus on selecting the most effective therapeutic drug, say for cancer, Inform Genomics Inc.’s focus with its lead product is to identify patients who have a genetic predisposition to specific side effects from cancer treatments. The company is looking across vast networks of genes to pinpoint characteristics that spell trouble for a patient. Each genetic profile is unique to the risks associated with a specific drug regimen: a patient’s profile may raise a red flag for severe side effects associated with one regimen, but may show that another regimen may be relatively safe.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice